ECTRIMS-MAGNIMS MAGNETIC RESONANCE IMAGING IN MULTIPLE SCLEROSIS FELLOWS Awardees

Similar documents
ECTRIMS-MAGNIMS MAGNETIC RESONANCE IMAGING IN MULTIPLE SCLEROSIS FELLOWS Awardees

May Letter from the President. Dear Colleagues,

ECTRIMS NEWSLETTER September Letter from the President

ECTRIMS NEWSLETTER May Letter from the President

ECTRIMS MULTIPLE SCLEROSIS CLINICAL TRAINING FELLOWS Awardees

ECTRIMS NEWSLETTER June Letter from the President

ECTRIMS NEWSLETTER September Letter from the President

Spinal cord MR imaging in Multiple Sclerosis

Primary Progressive MS. Predicting Progression. Alan J Thompson Director, UCL Institute of Neurology Queen Square

Clinical and research application of MRI in diagnosis and monitoring of multiple sclerosis

24 October 2017 Paris, France

ECTRIMS POSTDOCTORAL RESEARCH EXCHANGE FELLOWS Awardees

MRI diagnostic criteria for multiple sclerosis: an update

Dear Participants, Yours sincerely, Silvia Cristofanelli EXCEMED

30-31 October Milan, Italy

MRI MARKERS TO UNDERSTAND PROGRESSION MECHANISMS

Clinical and research application of MRI in diagnosis and monitoring of multiple sclerosis

MRI in MS: the radiologist perspective

Periventricular T2-hyperintense lesions: does the number matter in CIS?

Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis.

Quantitative Neuroimaging- Gray and white matter Alteration in Multiple Sclerosis. Lior Or-Bach Instructors: Prof. Anat Achiron Dr.

24-25 February Siena, Italy

Neurophysiology in diagnosis and monitoring of MS

MULTIPLE SCLEROSIS IN Managing the complexity of multiple sclerosis. Olga Ciccarelli and Alan Thompson

MORNING COFFEE

12-13 February Milan, Italy

Brain tissue and white matter lesion volume analysis in diabetes mellitus type 2

MRI in Multiple Sclerosis Features of Cerebral Atrophy with special focus on Multiple Sclerosis. E.W. Radue K. Bendfeldt Till Sprenger

T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis

EAN Amsterdam June 23-27, 2017

S. Valverde, X A. Oliver, Y. Díez, M. Cabezas, J.C. Vilanova, L. Ramió-Torrentà, À. Rovira, and X. Lladó

Association of asymptomatic spinal cord lesions and atrophy with disability. 5 years after a clinically isolated syndrome

effective national MS societies strengthened our capacity to facilitate for the rights of people affected by MS. We have

Visualisation of cortical MS lesions with MRI need not be further improved: Yes

Education around PML risk and monitoring at NHNN Queen Square MS Centre

Neurology and Neurometabolic Unit Department of Neurological and Behavioral Sciences University of Siena Siena, Italy

New Research on Neuraceq TM (florbetaben F18 injection) Imaging to be Presented at Annual Alzheimer s Association International Conference

ORIGINAL CONTRIBUTION. Normal-Appearing Brain T1 Relaxation Time Predicts Disability in Early Primary Progressive Multiple Sclerosis

ECTRIMS POSTDOCTORAL RESEARCH EXCHANGE FELLOWS Awardees

Anatomical applicability of current off-the-shelf branched endografts in thoracoabdominal aortic aneurysms managed by open surgery.

Cognitive Impairment and Magnetic Resonance Changes in Multiple Sclerosis. Background

MAGNIMS MRI in monitoring disease activity and progression

Neuroplasticity: functional MRI techniques M.A. Rocca

MEDIA BACKGROUNDER. Teriflunomide: A novel oral drug being investigated for the treatment of Multiple Sclerosis (MS)

MRI in ALS. Federica Agosta, MD, PhD

Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis

Supplementary Online Content

MRI in Leber s hereditary optic neuropathy: the relationship to multiple sclerosis

ORIGINAL CONTRIBUTION. Determinants of Cerebral Atrophy Rate at the Time of Diagnosis of Multiple Sclerosis. imaging (MRI) provides

SUPPLEMENTARY INFORMATION In format provided by Frank et al. (JULY 2010)

Curriculum Vitae: Angelo Antonini, MD, PhD

Positive Phase III results for Roche s investigational medicine OCREVUS (ocrelizumab) published in New England Journal of Medicine

Review of Longitudinal MRI Analysis for Brain Tumors. Elsa Angelini 17 Nov. 2006

Efficacy convenience of MS treatments. Xavier Montalban Department of Neurology-Neuroimmunology. ECF Baveno 2013

Published over 200 peer-reviewed papers, mainly in refereed international scientific journals.

Florence, Italy September 30 - October 1, 2011

Clinical Correlations of Brain Lesion Distribution in Multiple Sclerosis

Vascular complications after extracorporeal membrane oxygenation (ECMO) Alessandro Grandi

Honorary Clinical Senior Lecturer. Nervous Systems Disorders Speciality Lead. Neurology Long Term Conditions Clinical Lead

MS Cortical Lesions on DIR: Not Quite What They Seem?

The invisible facets of MS and everyday challenges clinician s perspective. Mar Tintore

Quantifying brain volumes for Multiple Sclerosis patients follow-up in clinical practice comparison of 1.5 and 3 Tesla magnetic resonance imaging

Case reports functional imaging in epilepsy

MRI dynamics of brain and spinal cord in progressive multiple sclerosis

MRI Acquisition and Analysis Protocol for In Vivo Intraorbital Optic Nerve Segmentation at 3T

Dear Participants, Yours sincerely, Silvia Cristofanelli EXCEMED

Multi- spectral characterization of thalamic nuclei using 3T MRI

High-fidelity Imaging Response Detection in Multiple Sclerosis

Topics in Neuroscience

Structural lesion analysis: applications

ORIGINAL CONTRIBUTION. Axonal Injury and Overall Tissue Loss Are Not Related in Primary Progressive Multiple Sclerosis

26 November Lima, Perù

Supplementary online data

ADVANCE APPROACH FOR IDENTIFICATION WHITE MATTER FROM BRAIN MRI IMAGES AND CLASSIFICATION

OMICS Group. Contact us at:

Investigators meeting. Thursday 7 June 2012

Target audience. Jorge Correale Department of Neurology Raúl Carrea Institute for Neurological Research (FLENI) Buenos Aires, Argentina

The new Global Multiple Sclerosis Severity Score (MSSS) correlates with axonal but not glial biomarkers

Advanced multimodal imaging in malformations of cortical development

A journey from the past to the future of multiple sclerosis

Rehabilitation and symptomatic treatment in multiple sclerosis

Clinical trials of multiple sclerosis monitored with enhanced MRI: new sample size calculations based on large data sets

NEW DIAGNOSTIC CRITERIA FOR MULTIPLE SCLEROSIS

Neuroimaging and Other Biomarkers. MRI for Diagnosis, Prognosis and Treatment Decisions in MS

Supplementary Online Content

Anatomical MRI and DTI in the Diagnosis of Alzheimer s Disease: A European Multicenter Study

Synopsis (88 words) Purpose (74) Methods (341)

All relapsing multiple sclerosis patients should be managed at a specialist clinic- YES. Dr W J Brownlee FRACP 1. O Ciccarelli FRCP 1,2

Machine learning approaches for clinical neuroimaging data

Cover Page. The handle holds various files of this Leiden University dissertation

APPLICATION OF PHOTOGRAMMETRY TO BRAIN ANATOMY

Ramasamy, Deepa Preeti MD. Education. Certifications

Neural control of the lower urinary tract in health and disease

Neuroradiological, clinical and genetic characterization of new forms of hereditary leukoencephalopathies

VIDEO SURVEILLANCE AND BIOMEDICAL IMAGING Research Activities and Technology Transfer at PAVIS

MRI CRITERIA FOR THE DIAGNOSIS OF MULTIPLE SCLEROSIS: THE 2015

ADULT-ONSET (INFRATENTORIAL) LEUKOENCEPHALOPATHY as PRESENTING MANIFESTATION of ERDHEIM-CHESTER DISEASE

UNIVERSITY HOSPITAL VALL D HEBRON EXPERIENCE LINKED TO THE ACCORD PROGRAMME

Assessing treatment outcomes in multiple sclerosis trials and the clinical

Patologie infiammatorie encefaliche e midollari

Transcription:

ECTRIMS-MAGNIMS MAGNETIC RESONANCE IMAGING IN MULTIPLE SCLEROSIS FELLOWS 2018 Awardees Alberto Calvi, PhD Slowly Evolving Lesions (SELs) in multiple sclerosis Queen Square Multiple Sclerosis Centre, University College London, United Kingdom Prof. Barkhof and Prof. Ciccarelli Margareta Clarke, PhD Iron rims around multiple sclerosis lesions. A new MRI marker of disease activity and progression? Hospital Universitari Vall d Hebron, Barcelona, Spain Prof. Rovira ECTRIMS-MAGNIMS MRI in Multiple Sclerosis Fellows page 1

2017 Awardees Soheil Damangir, PhD Optimizing crowd-sourced solutions toward generating large reference datasets for WM lesion segmentation in MS VU University Medical Center, Amsterdam, Netherlands with collaboration at the Vall d Hebron University Hospital, Barcelona, Spain Dr. Vrenken and Prof. Barkhof Marcello Moccia, PhD Improving longitudinal spinal cord atrophy measurements for clinical trials in multiple sclerosis by using the Generalised Boundary Shift Integral (GBSI) UCL Institute of Neurology, National Hospital for Neurology & Neurosurgery, Queen Square, London, United Kingdom Prof. Ciccarelli and Prof. Barkhof 2016 Awardees Alessandro d Ambrosio, MD Relating functional connectivity to cognition in multiple sclerosis: from stationary to time-varying analysis of strategic large-scale networks Ospedale San Raffaele, Neuroimaging Research Unit, Milan, Italy ECTRIMS-MAGNIMS MRI in Multiple Sclerosis Fellows page 2

Sara Collorone, MD To investigate how longitudinal changes in Structural Cortical Networks relate to disease evolution in Clinically Isolated Syndrome using 3D T1-weighted high-resolution scans from the MAGNIMS CIS cohort UCL Institute of Neurology, National Hospital for Neurology & Neurosurgery, Queen Square, London, UK Dr. Ahmed Toosy and Prof. Frederik Barkhof 2015 Awardees Mohammad Aboulwafa, MD Whole-cord and voxel-based assessment of cervical cord atrophy in MS patients with different clinical phenotypes: a multi-centre assessment Neuroimaging Research Unit, INSPE, Division of Neuroscience, San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy Arman Eshaghi, MD, PhD To explore imaging phenotypes of patients with multiple sclerosis using 4-dimensional voxel-based morphometry UCL Institute of Neurology, National Hospital for Neurology & Neurosurgery, Queen Square, London, UK Prof. Olga Ciccarelli ECTRIMS-MAGNIMS MRI in Multiple Sclerosis Fellows page 3

2014 Awardees Mariano Cabezas Grebol, PhD Automatic detection and analysis of new lesions in serial MRI of MS patients Fundacio Hospital Universitari Vall d'hebron, Institut de Recerca, Barcelona, Spain Dr. Alex Rovira Yaou Liu, MD, PhD Validation of deep gray matter atrophy measurement in Multiple Sclerosis for multi-center studies: a MUSCAT project MS Center Amsterdam, VU University Medical Center, Amsterdam, Netherlands Prof. Frederic Barkhof 2013 Awardees Alvino Bisecco, MD Disconnection and regional WM change WRT cognition in setting of Multicentre MAGNIMS study Neuroimaging Research Unit, INSPE, Division of Neuroscience, San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy ECTRIMS-MAGNIMS MRI in Multiple Sclerosis Fellows page 4

2012 Awardees Özgür Yaldizli, MD The dynamics of cortical grey matter lesion and non-lesional abnormalities and its correlation with clinical and cognitive measures in MS: a serial magnetic resonance imaging study University College of London, London, United Kingdom Prof. David Miller Georgina Arrambide, MD Contribution of 3T MRI and spinal cord MRI to the diagnosis of adult and paediatric patients with clinically isolated syndromes suggestive of Multiple Sclerosis Multiple Sclerosis Centre of Catalonia, Hospital Vall d Hebron, Barcelona, Spain Dr. Alex Rovira / Prof. Xavier Montalban 2011 Awardees Marco Battaglini, PhD Development of novel multimodal segmentation techniques to improve quantitative assessment of MR images in MS Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK Prof. Jacqueline Palace ECTRIMS-MAGNIMS MRI in Multiple Sclerosis Fellows page 5

Dušan Damjanović, MD Common Dataset project Neuroimaging Research Unit, INSPE, Division of Neuroscience, San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy 2010 Awardees Benedetta Bodini, MD, PhD Is grey matter damage secondary to white matter abnormalities in different MS subtypes? Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy Prof. Nicola de Stefano Veronica Popescu, MD Investigating the long-term clinical predictability of atrophy. Further refinement of post-processing procedures obviating the need for manual correction and application to 3D data-sets MS Center Amsterdam, VU University Medical Center, Amsterdam, Netherlands Prof. Frederik Barkhof ECTRIMS-MAGNIMS MRI in Multiple Sclerosis Fellows page 6